Business Segments · Impairments

Oral, Personal and Home Care — Impairments

Colgate-Palmolive Oral, Personal and Home Care — Impairments remained flat by 0.0% to $145.50M in Q4 2025 compared to the prior quarter. Over 3 years (FY 2021 to FY 2025), Oral, Personal and Home Care — Impairments shows an upward trend with a 16.6% CAGR. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementSegment
CategoryRisk
SignalLower is better
VolatilityVolatile
First reportedQ1 2021
Last reportedQ4 2025

How to read this metric

An increase in impairments is a negative signal indicating that previous investments or assets are underperforming expectations.

Detailed definition

This metric represents a non-cash charge taken when the carrying value of an asset, such as goodwill or long-lived asset...

Peer comparison

Reported as 'Asset Impairment Charges' or 'Write-downs' across all industries under GAAP/IFRS standards.

Metric ID: cl_segment_total_oral_personal_and_home_care_impairments

Historical Data

4 years
 FY'21FY'22FY'23FY'25
Value$367.00M$332.00M$0.00$582.00M
YoY Change-9.5%-100.0%
Range$0.00$582.00M
CAGR+16.6%
Avg YoY Growth-54.8%
Median YoY Growth-54.8%

Frequently Asked Questions

What is Colgate-Palmolive's oral, personal and home care — impairments?
Colgate-Palmolive (CL) reported oral, personal and home care — impairments of $145.50M in Q4 2025.
What is the long-term trend for Colgate-Palmolive's oral, personal and home care — impairments?
Over 3 years (2021 to 2025), Colgate-Palmolive's oral, personal and home care — impairments has grown at a 16.6% compound annual growth rate (CAGR), from $367.00M to $582.00M.
What does oral, personal and home care — impairments mean?
A non-cash expense recognized when the value of an asset is written down because it is worth less than its recorded book value.